M. Moasser
Oncology · 2007–2008
A researcher in the Science corpus: 3 papers; trusts 16 researchers and is trusted by 5 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 51 citations into it; #209 of 1,698 by trust here, #1,080 by citations
- Molecular Biology — 37 citations into it
- Radiology, Nuclear Medicine and Imaging — 23 citations into it; #652 of 3,265 by trust here, #1,550 by citations
Whom M. Moasser trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Y. Yarden
- I. Weinstein
- Waltraud X. Schulze
- Hyun-soo Cho
- J. Mendelsohn
- J. Testa
- M. Sliwkowski
- H. Shigematsu
- J. Baselga
- Gerard Manning
Who trusts M. Moasser overall
Papers from M. Moasser's perspective
Ordered by how strongly the researchers M. Moasser trusts endorse each paper. Same corpus, a different order for every researcher.
- Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab (Nature)
- The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors. (Molecules and Cells)
- Anticancer drugs: To the rescue? (Nature reviews. Drug discovery)
- Molecular portraits of human breast tumours (Nature)
- Structure of the Epidermal Growth Factor Receptor Kinase Domain Alone and in Complex with a 4-Anilinoquinazoline Inhibitor* (Journal of Biological Chemistry)
- Addiction to Oncogenes--the Achilles Heal of Cancer (Science)
- An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors. (Molecules and Cells)
- ERBB Receptors and Cancer: The Complexity of Targeted Inhibitors (Nature Reviews. Cancer)
- Momentous sprint at the 2156 Olympics? (Nature)
- Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex. (Cancer Cell)
Their papers
- The epidermal growth factor receptor family: Biology driving targeted therapeutics (2008) — 730 citations
- The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis (2007) — 1,158 citations
- Escape from HER family tyrosine kinase inhibitor therapy by the kinase inactive HER3 (2007) — 1,006 citations